- The quality or safety of any intervention used in the trial All substantial amendments will be notified to the ERB, the competent authority and subsidizing party/study (AstraZeneca). Non-substantial amendments will not be notified to ERB and competent authority, but will be recorded and filed by the sponsor/investigator and reported to AstraZeneca.